BRASTER S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.58 PLN | 0.00% |
|
0.00% | 0.00% |
| 2023 | Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| 2023 | Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2021 | 436K 111K | Sales 2022 | 2.24M 570K | Capitalization | 22.06M 5.62M |
|---|---|---|---|---|---|
| Net income 2021 | -6M -1.53M | Net income 2022 | -3M -764K | EV / Sales 2021 | 82.6 x |
| Net Debt 2021 | 13.35M 3.4M | Net Debt 2022 | 12.42M 3.16M | EV / Sales 2022 | 15.4 x |
| P/E ratio 2021 |
-3.39
x | P/E ratio 2022 |
-5.18
x | Employees | 14 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 76.08% |
More Fundamentals
* Assessed data
More news
3 years
0.53
1.52
5 years
0.192.88
10 years
0.1930.00
| Managers | Title | Age | Since |
|---|---|---|---|
Dariusz Karolak
CEO | Chief Executive Officer | - | 09-12-31 |
| Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 0.58 | 0.00% | 0 |
| 24-05-14 | 0.58 | 0.00% | 0 |
| 24-05-13 | 0.58 | 0.00% | 0 |
| 24-05-10 | 0.58 | 0.00% | 0 |
| 24-05-09 | 0.58 | 0.00% | 0 |
Delayed Quote Warsaw S.E., May 16, 2024 at 11:55 am EDT
More quotes
Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 4.35M | |
| -30.64% | 9.59B | |
| -5.06% | 3.21B | |
| +28.04% | 2.92B | |
| -14.73% | 2.15B | |
| -16.07% | 1.79B | |
| +68.70% | 1.47B | |
| +24.92% | 770M | |
| -2.84% | 761M | |
| -26.43% | 548M |
- Stock Market
- Equities
- BRA Stock
